Cancer groups warn of unequal access after Kela subsidy change
Finnish cancer patient organisations have raised concerns over unequal access to treatment after the Social Insurance Institution (Kela) stopped reimbursing certain expensive cancer drugs when…
Read the full articleYou might also wanna read
European Multiple Myeloma Patients Face Unequal Access to Curative Treatments
Lack of access to innovative and effective treatments compromises survival outcomes for many patients in Europe with multiple myeloma.
Australia's slow progress on equitable cancer prostheses access harms rural patients, analyst warns
Efforts to ensure cancer patients have equitable access to vital prostheses are progressing intolerably slowly, with devastating consequence
Finnish Deputy Ombudsman warns healthcare fee hikes threaten fundamental rights and may worsen health inequalities
Uudet maksut ja maksujen korotukset ovat apuoikeusasiamiehen mukaan ”huomattavan suuria.”
Disparities in Mental Health Screening and Support
Conditions : Mental Health; Cancer Sponsors : European Institute of Oncology; Institut Català d'Oncologia; Hospital Sant Joan de Deu; ORGANI
What’s going on with ACA subsidies?
After temporary Affordable Care Act subsidies expired at the end of 2025, enrollees may face higher premiums in 2026.

AstraZeneca to pull breast cancer and endometriosis drug Zoladex from Australian market in November
The vital medicine, made by AstraZeneca, will not be available from November, possibly leaving thousands of women without treatment

Comments
Sign in to join the conversation.
No comments yet. Be the first.